Vulcan Energy: Injection Test Beats the Blueprint as Lithium Sentiment Weighs on the Stock

Vulcan Energy has delivered a technical result that lands squarely where the company wanted it to: above its own planning assumption. The seventh well in the Lionheart programme, LSC-3a, saw the company pump lithium-poor brine back into the sandstone reservoir matrix for the first time. Under the intended operating conditions, modelling produced an injection capacity of roughly 64 standard litres per second, against the approximately 40 standard litres per second Vulcan had pencilled in for such matrix injectors. Management says the trial directly validates a core assumption of the Lionheart base case, and that the three new wells drilled so far have met or exceeded planning expectations.

That is a stronger foundation for the next phase rather than proof of a working plant. The distinction matters, because the figure is modelled performance under future operating conditions, not a rate measured at surface. The data will now feed into planning for the follow-up injection wells LSC-4 and LSC-5 — the point at which a technical result starts to carry tangible economic weight, by reducing a specific uncertainty inside the project.

A second track: making the extraction material in-house

Running alongside the subsurface work is Vulcan's push to control its own consumables. Commercial-scale output of VULSORB, the company's proprietary adsorbent for direct lithium extraction at Lionheart, began on 21 September in Germany. The first volumes are earmarked for the initial fill of the Lionheart extraction columns, with commissioning targeted for the second half of 2028. By keeping formulation and manufacturing in-house, Vulcan aims to cut its dependence on outside suppliers.

Taken together, the two announcements sketch an integration story rather than a single-commodity one. Lionheart is designed to pair raw material extraction with energy generation: 24,000 tonnes of lithium hydroxide monohydrate a year, plus 275 GWh of renewable electricity and 560 GWh of heat. Those are project targets, not current output, and the development assumptions still rest on the 2023 study — provisional by definition. The industrial promise lies in combining those outputs, not in the lithium alone.

Why the share price is telling a different story

None of that has translated into a positive tape. The stock is down 5.0% on the day of the drilling update, and the company's announcement offers no explanation for the move. The weakness is not a Vulcan-specific story. On Tuesday, the shares came under pressure with no price-relevant corporate news at all, shedding 12.4% according to media reports, while other lithium names gave up between 4% and 8%. The drag came from persistently soft lithium prices and lower Chinese futures for lithium carbonate, compounded by demand worries tied to the EU's push to curb Chinese hybrid imports.

That backdrop explains Tuesday's market environment; it does not automatically account for the latest session's decline. For investors, the split is the useful part: technical progress on a single project and expectations for lithium demand sit on different levels of the valuation. A successful reinjection test firms up one building block of the Lionheart plan. It does not lift the sector's gloom — and it is not a verdict on future lithium prices or on the project's overall economics. What remains decisive is how reliably those individually confirmed pieces add up to a system that runs.